Sign In
Buy DXCM
$86.94
-0.370 (-0.424%)
At Close: Aug 04, 2026
DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript
08:58pm, Wednesday, 30'th Jul 2025
DexCom, Inc. (NASDAQ:DXCM ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Jacob Steven Leach - President & COO Jereme M. Sylvain - Executive VP, CFO & Chief Accounting
Compared to Estimates, DexCom (DXCM) Q2 Earnings: A Look at Key Metrics
07:01pm, Wednesday, 30'th Jul 2025
Although the revenue and EPS for DexCom (DXCM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street es
DexCom (DXCM) Q2 Earnings and Revenues Top Estimates
06:16pm, Wednesday, 30'th Jul 2025
DexCom (DXCM) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.43 per share a year ago.
Dexcom beats estimates for quarterly results, names new CEO
05:23pm, Wednesday, 30'th Jul 2025
Dexcom beat estimates for second-quarter results on Wednesday, driven by strong demand for its continuous glucose monitors, and named Jake Leach as its CEO.
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
04:02pm, Wednesday, 30'th Jul 2025
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan.
Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program
08:00am, Wednesday, 30'th Jul 2025
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 Continu
DexCom (DXCM) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
01:06am, Tuesday, 29'th Jul 2025
Besides Wall Street's top-and-bottom-line estimates for DexCom (DXCM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quar
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
08:30am, Monday, 28'th Jul 2025
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc., the global leader in glucose biosensing, announced today it has released a new AI-powered photo meal logging feature to Stelo, the first over-the-counter gluc
Will DXCM Q2 Earnings Reflect U.S. Coverage Expansion & Stelo Impact?
11:16am, Thursday, 24'th Jul 2025
DexCom Q2 results are likely to reflect strong growth on the back of coverage by two large PBMs and Stelo traction, driving momentum and market expansion in 2025.
Tenovi Expands Access to Glucose Data for Remote Patient Monitoring and Cardiometabolic Programs Through Dexcom Integration
07:45am, Wednesday, 23'rd Jul 2025
PORTSMOUTH, N.H.--(BUSINESS WIRE)-- #care--Tenovi, a leading provider of remote patient monitoring (RPM) solutions, today announced it now supports Dexcom continuous glucose monitoring (CGM) data dire
DexCom: Delivering Consistent Growth
11:26am, Monday, 21'st Jul 2025
DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Q1 results showed 13% revenue growth, beating expectations, though earnings were slightly below
Are Medical Stocks Lagging DexCom (DXCM) This Year?
10:41am, Monday, 21'st Jul 2025
Here is how DexCom (DXCM) and Amarin (AMRN) have performed compared to their sector so far this year.
Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years
08:45am, Sunday, 20'th Jul 2025
Medical device specialist DexCom (DXCM -0.33%) has encountered significant headwinds in the past year. The company's financial results haven't been quite up to the market's standards, and broader mark
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
08:30am, Thursday, 17'th Jul 2025
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of Dexcom U, the company's one-of-a-kind NIL (Name, Im
DexCom (DXCM) Upgraded to Strong Buy: Here's What You Should Know
01:01pm, Monday, 14'th Jul 2025
DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
